XML 43 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Measurements [Abstract]  
Liabilities Measured at Fair Value on a Recurring Basis
The following tables summarize the Company’s liabilities which were measured at fair value on a recurring basis as of the periods presented and their classification within the fair value hierarchy:

   
Fair Value Measurement as of March 31, 2026
 
   
Total
   
Level 1
   
Level 2
   
Level 3
 
   
(In thousands)
 
Liabilities:
                       
Commodity derivative contracts
 
$
109,445
   
$
   
$
109,445
   
$
 
Subordinated note warrants – related party
 
$
725
   
$
   
$
   
$
725
 
Series F Preferred Stock embedded derivatives
 
$
15,806
   
$
   
$
   
$
15,806
 
Series F Preferred Stock warrants
 
$
114,433
   
$
   
$
   
$
114,433
 

   
Fair Value Measurement as of December 31, 2025
 
   
Total
   
Level 1
   
Level 2
   
Level 3
 
   
(In thousands)
 
Assets:
                       
Commodity derivative contracts
 
$
53,439
   
$
   
$
53,439
   
$
 
                                 
Liabilities:
                               
Subordinated note warrants – related party
 
$
316
   
$
   
$
   
$
316
 
Series F Preferred Stock embedded derivatives
 
$
15,853
   
$
   
$
   
$
15,853
 
Series F Preferred Stock warrants
 
$
90,134
   
$
   
$
   
$
90,134
 
Reconciliation of Financial Instruments Presented at Fair Value The following table presents the changes in the Company’s financial instruments presented at fair value for the periods indicated:
   
March 31, 2026
   
December 31,
2025
 
   
(In thousands)
 
Subordinated note warrants – related party, at the beginning of the period
 
$
316
   
$
4,159
 
Loss (gain) on adjustment to fair value
   
409
     
(3,843
)
Subordinated note warrants – related party, at the end of the period
 
$
725
   
$
316
 
                 
Series F Preferred Stock embedded derivatives, at the beginning of the period
 
$
15,853
   
$
 
Embedded derivatives recognized at issuance of Series F Preferred Stock
   
     
25,479
 
Gain on adjustment to fair value
   
(47
)
   
(9,626
)
Series F Preferred Stock embedded derivatives, at the end of the period
 
$
15,806
   
$
15,853
 
                 
Series F Preferred Stock warrants, at the beginning of the period
 
$
90,134
   
$
 
Issuance of Series F Preferred Stock
   
     
22,115
 
Loss on adjustment to fair value
   
24,299
     
68,019
 
Series F Preferred Stock warrants, at the end of the period
 
$
114,433
   
$
90,134
 
Fair Value on Financial Instrument Balance Sheets
The following table presents the face value and fair value of each financial instrument presented at fair value on the Company’s condensed consolidated balance sheets as of the periods presented:

   
March 31, 2026
   
December 31, 2025
 
   
Face Value
   
Fair Value
   
Face Value
   
Fair Value
 
   
(In thousands)
 
Subordinated note warrants – related party
 
$
   
$
725
   
$
   
$
316
 
Series F Preferred Stock embedded derivatives
   
     
15,806
     
   
$
15,853
 
Series F Preferred Stock warrants
 
$
   
$
114,433
   
$
   
$
90,134
 
Fair Value Instruments Unobservable Market Data
The Company engaged a third–party valuation expert to assist in preparing the fair value of the Subordinated Note Warrants as of March 31, 2026 and December 31, 2025. These estimates were derived using a Monte Carlo simulation model using the significant inputs listed below, which are based on unobservable market data and are therefore considered Level 3 inputs within the fair value hierarchy.

   
Key Inputs
 
Subordinated Note Warrants – Monte Carlo Simulation Model
 
March 31, 2026
   
December 31,
2025
 
Time to termination (years)
   
3.50
     
3.75
 
Stock price – as of period indicated
 
$
2.03
   
$
1.69
 
Exercise price
 
$
8.89
   
$
8.89
 
Risk–free rate
   
3.77
%
   
3.55
%
Equity volatility rate
   
120.0
%
   
85.0
%
The Company engaged a third-party valuation expert to assist in preparing the fair value of the Series F Preferred Stock embedded derivatives as of March 31, 2026 and December 31, 2025. These estimates were derived using a Monte Carlo simulation model using the significant inputs listed below, which are based on unobservable market data and are therefore considered Level 3 inputs within the fair value hierarchy.

   
Key Inputs
 
Series F Preferred Stock Embedded Derivatives – Monte Carlo Simulation Model
 
March 31, 2026
   
December 31,
2025
 
Time to termination (years)
   
3.49
     
3.16
 
Stock price – as of period indicated
 
$
2.03
   
$
1.69
 
Conversion rate
   
202.02
     
202.02
 
Stated dividend rate
   
12.0
%
   
12.0
%
Transaction discount
   
30.4
%
   
32.5
%
Risk-free rate
   
3.77
%
   
3.50
%
Preferred equity volatility rate
   
72.0
%
   
54.0
%
The Company engaged a third-party valuation expert to assist in preparing the fair value of the Series F Preferred Stock Warrants as of March 31, 2026 and December 31, 2025. These estimates were derived using a Monte Carlo simulation model using the significant inputs listed below, which are based on unobservable market data and are therefore considered Level 3 inputs within the fair value hierarchy.

   
Key Inputs
 
Series F Preferred Stock Warrants – Monte Carlo Simulation Model
 
March 31, 2026
   
December 31,
2025
 
Time to termination (years)
   
4.99
     
5.23
 
Stock price – as of period indicated
 
$
2.03
   
$
1.69
 
Exercise price
 
$
1.894
   
$
2.047
 
Future value of one Series F Preferred Stock Warrant share
 
$
1.64
   
$
0.31
 
Risk-free rate
   
3.84
%
   
3.69
%
Equity volatility rate
   
110.0
%
   
85.0
%